Review analyses the trajectory of biologic APIs

08:24 EDT 1 Oct 2019 | Manufacturing Chemist

Kline review has predicted that growth of biologics and biosimilars will drive above-average demand for a range of ingredients through 2023

Original Article: Review analyses the trajectory of biologic APIs


More From BioPortfolio on "Review analyses the trajectory of biologic APIs"

Quick Search

Relevant Topics

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...